The Bax-Anti Bcl2 combination module driven by artificial hTERT promoter could availably and selectively over-express Bax gene and interference sequence of Bcl2 to reverse the ratio of Bcl2/Bax for intervention of malignant phenotype of bladder cancer cells. This evidence concerns the gene BCL2 and urinary bladder cancer.